智通财经APP获悉，剂泰科技-P(07666)盘中涨超3%，近五个交易日累计涨幅已超20%，总市值突破170亿港元。
消息面上，剂泰科技近日宣布，与全球顶级健康投资与创新平台Deerfield达成战略联盟。双方的战略联盟旨在深度整合剂泰科技在AI驱动蛋白工程、体内免疫治疗及可编程生物药领域的专有差异化技术和Deerfield在转化医学、临床开发、医疗健康创新及全球合作等方面深厚的产业经验和专业能力。
据悉，Deerfield将就剂泰科技自研AI纳米递送平台NanoForge及其驱动解决方案和核心管线项目在全球临床开发和商务拓展举措方面开展深度合作。其中包括剂泰科技自研AiProtein平台发现并推进至临床前候选药物阶段的一项领先T细胞衔接器（TCE）项目。Deerfield将进一步探索该项目潜在授权与开发机会，以推动其进入IND支持性研究和临床开发阶段。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.